Company Description
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People’s Republic of China.
It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations.
The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as technological promotion services and import and export.
The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021.
Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.
Country | China |
Founded | 2013 |
Industry | Medical Distribution |
Sector | Healthcare |
Employees | 27 |
CEO | Yilin Wang |
Contact Details
Address: Qiantongyuan Building, Room 8201-4-4(A) Qingdao China | |
Phone | 86 15 2100 54919 |
Website | ahgtop.com |
Stock Details
Ticker Symbol | AHG |
Exchange | NASDAQ |
Fiscal Year | April - March |
Reporting Currency | USD |
CIK Code | 0001702318 |
CUSIP Number | 98422P108 |
ISIN Number | US98422P1084 |
SIC Code | 7389 |
Key Executives
Name | Position |
---|---|
Yilin Wang | Chief Executive Officer and Chairwoman of the Board |
Zhongliang Xie | Chief Financial Officer |
Daisy Wang | Investor Relation Contact |
Ma Xiaoqin | Corporate Secretary |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Aug 14, 2025 | 20-F | Annual and transition report of foreign private issuers |
Jul 31, 2025 | NT 20-F | Notification of inability to timely file Form 20-F |
Jun 6, 2025 | EFFECT | Notice of Effectiveness |
May 22, 2025 | F-3/A | Filing |
May 1, 2025 | 6-K | Report of foreign issuer |
Mar 28, 2025 | 6-K | Report of foreign issuer |
Jan 30, 2025 | UPLOAD | Filing |
Jan 6, 2025 | F-3/A | Filing |
Dec 17, 2024 | UPLOAD | Filing |
Nov 26, 2024 | F-3/A | Filing |